![](https://endpts.com/wp-content/uploads/2020/11/Bobby-Gaspar-Orchard-tile-scaled.jpg)
Bobby Gaspar, Orchard Therapeutics CEO
FDA greenlights Orchard's gene therapy Lenmeldy for rare and fatal disease
The FDA approved a gene therapy known as Lenmeldy for early-onset metachromatic leukodystrophy, or MLD, a rare and fatal genetic disease …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.